Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steinhardt

Showing results (721-730 of 741) with videos related to

Pageof 75
Sort By:
Communications Biology|December 22, 2023
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple MyelomaUmair Munawar, Xiang Zhou, Sabrina Prommersberger, et al.
Bioengineering (Basel, Switzerland)|March 27, 2024
Standardization of a CT Protocol for Imaging Patients with Suspected COVID-19-A RACOON ProjectAndrea Steuwe, Benedikt Kamp, Saif Afat, et al.
PLOS Global Public Health|March 24, 2023
Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household surveyRosemary A Audu, Kristen A Stafford, Laura Steinhardt, et al.
Blood Advances|April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL AmyloidosisMaximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Frontiers in Immunology|November 17, 2022
Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacyNatasha Kc, L W Preston Church, Pouria Riyahi, et al.
Nature Medicine|September 14, 2021
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trialMartina Oneko, Laura C Steinhardt, Reuben Yego, et al.
Plos One|April 1, 2022
Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in NigeriaNnaemeka C Iriemenam, Fehintola A Ige, Stacie M Greby, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Environmental Sciences Europe|November 15, 2016
Since 2015 the SinoGerman research project SIGN supports water quality improvement in the Taihu region, ChinaKathrin Rachel Schmidt, Tim Aus der Beek, Xiaohu Dai, et al.
Scientific Reports|August 10, 2025
SARS-CoV-2 seroprevalence and COVID-19 vaccination coverage in two states of Nigeria from a population based household surveyNwachukwu William Enyereibe, Elsie Ilori, Laura Steinhardt, et al.
Pageof 75

Showing results (721-730 of 741) with videos related to

Sort By:
Pageof 75
Communications Biology|December 22, 2023
Impaired FADD/BID signaling mediates cross-resistance to immunotherapy in Multiple MyelomaUmair Munawar, Xiang Zhou, Sabrina Prommersberger, et al.
Bioengineering (Basel, Switzerland)|March 27, 2024
Standardization of a CT Protocol for Imaging Patients with Suspected COVID-19-A RACOON ProjectAndrea Steuwe, Benedikt Kamp, Saif Afat, et al.
PLOS Global Public Health|March 24, 2023
Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household surveyRosemary A Audu, Kristen A Stafford, Laura Steinhardt, et al.
Blood Advances|April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL AmyloidosisMaximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Frontiers in Immunology|November 17, 2022
Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacyNatasha Kc, L W Preston Church, Pouria Riyahi, et al.
Nature Medicine|September 14, 2021
Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trialMartina Oneko, Laura C Steinhardt, Reuben Yego, et al.
Plos One|April 1, 2022
Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in NigeriaNnaemeka C Iriemenam, Fehintola A Ige, Stacie M Greby, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animalsSeth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Environmental Sciences Europe|November 15, 2016
Since 2015 the SinoGerman research project SIGN supports water quality improvement in the Taihu region, ChinaKathrin Rachel Schmidt, Tim Aus der Beek, Xiaohu Dai, et al.
Scientific Reports|August 10, 2025
SARS-CoV-2 seroprevalence and COVID-19 vaccination coverage in two states of Nigeria from a population based household surveyNwachukwu William Enyereibe, Elsie Ilori, Laura Steinhardt, et al.
Pageof 75